Ripple

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: Ripple
Generic name: GLYCERIN, POVIDONE
Manufacturer: CorneaCare Inc
Product type: HUMAN OTC DRUG
SPL set ID: 3b5ba197-d501-681e-e063-6294a90aefb5
SPL ID: 528a38d6-82f4-0572-e063-6394a90afd85
Version: 3
Effective date: 2026-05-24
Source export date: 2026-09-28
Source partition: 6
Source file: https://download.open.fda.gov/drug/label/drug-label-0006-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-09-28/e0861bcde1444ef952820955caafc6f3fd29783e5ade07a13d933aa3336b399f/drug-label-0006-of-0014.json.zip
Source manifest SHA-256: cd2e66336a5cd2223fa3995098fdbdb84c6a7ee5c0a4addb236ccb22dd1e6887
Import run: 20260929T050834Z
Imported at: 2026-09-29 05:36:22

Harmonized routes table
Harmonized routes
OPHTHALMIC

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 12 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
application number		M018	openfda.application_number
brand name		Ripple	openfda.brand_name
generic name		GLYCERIN, POVIDONE	openfda.generic_name
manufacturer name		CorneaCare Inc	openfda.manufacturer_name
ndc	package	82875-003-10	openfda.package_ndc
ndc	product	82875-003	openfda.product_ndc
ndc11	package	82875000310	derived:openfda.package_ndc
rxcui		2625120	openfda.rxcui
spl id		528a38d6-82f4-0572-e063-6394a90afd85	id
spl set id		3b5ba197-d501-681e-e063-6294a90aefb5	set_id
unii		PDC6A3C0OX	openfda.unii
unii		FZ989GH94E	openfda.unii

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Warnings For external use only Do not use ■If solution changes color or becomes cloudy. ■lf you are sensitive to any ingredient in this product. When using this product ■Do not touch tip of container to any surface to avoid contamination. ■Replace cap after using. Stop use and ask a doctor if ■You experience eye pain, changes in vision, continued redness or irritation of the eye. ■ Condition worsens or persists for more than 72 hours.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.